A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature
- PMID: 22732950
- PMCID: PMC3726263
- DOI: 10.1097/MD.0b013e3182606f0b
A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature
Abstract
Melanoma differentiation-associated protein 5 (MDA-5) is a novel autoantibody frequently characterized by interstitial lung disease and a distinct cutaneous phenotype with palmar papules, ulceration, and rash. Virtually all patients have underlying dermatomyositis, but many lack the characteristic clinical myopathy associated with it. In the setting of amyopathic disease, the absence of clinically available biomarkers or clear pathologic diagnosis can complicate effective prognostic and therapeutic intervention. Until recently the presence of MDA-5 antibody associated dermato-pulmonary syndrome was described only in Asian populations. We present 2 cases of MDA-5-associated dermato-pulmonary syndrome and provide a comprehensive review of available literature.
Conflict of interest statement
Conflicts of interest
The authors have no conflicts of interest to disclose.
Figures
References
-
- . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;18:1301–1308. - PubMed
-
- Casciola-Rosen LA, Pluta AF, Plotz PH, Cox AE, Morris S, Wigley FM, Petri M, Gelber AC, Rosen A. The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen. Arthritis Rheum. 2001;44:389–396. - PubMed
-
- Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis sine myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol. 1991;24:959–966. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
